Rubius Therapeutics (RUBY) stock is heading higher on Tuesday despite a lack of news from the cellular medicines company.More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live …
More Why Is Rubius Therapeutics (RUBY) Stock Up 35% Today? Videos